Guaral +ST app.
ADVERSE EVENTS
a) Initial screen of the app. b) Screen for registering the administered dose of treatment. c) Screen for registering injection site reactions. d) Lesion photographs registered via the app.We conducted a randomized trial to evaluate the performance of the app in the hands of CHV. We did not hypothesize that the intervention would improve outcomes of the initial treatment but rather that it would result in more complete data on treatment outcomes and adverse events. The trial had parallel arms comparing a) follow-up by community health volunteers aided by the app to b) standard institution-based follow-up. A non-randomized control group was added later (see below). The trial, including its protocol, was retrospectively registered with ISRCTN, reference number ISRCTN54865992 (